The Clorox Company (NYSE:CLX – Get Free Report) has been given an average rating of “Reduce” by the fifteen analysts that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $155.00.
Several equities research analysts recently weighed in on CLX shares. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Citigroup upped their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st.
Read Our Latest Analysis on Clorox
Institutional Investors Weigh In On Clorox
Clorox Stock Up 0.2 %
CLX stock opened at $167.73 on Friday. The firm has a 50-day moving average price of $163.59 and a 200-day moving average price of $150.86. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $20.76 billion, a P/E ratio of 58.42, a price-to-earnings-growth ratio of 3.08 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. As a group, equities research analysts anticipate that Clorox will post 6.85 EPS for the current fiscal year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.04%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- Business Services Stocks Investing
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Most Volatile Stocks, What Investors Need to Know
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.